Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-04-13 @ 7:59 AM
Study NCT ID:
NCT03047993
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2017-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-03
First Submit QC Date:
None
Study First Post Date:
2017-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-03-15
Results First Submit QC Date:
None
Results First Post Date:
2024-05-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-05-14
Last Update Post Date Type:
ACTUAL